202 related articles for article (PubMed ID: 28631775)
41. Corrigendum to "Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer" [Gynecologic Oncology Volume 161, Issue 3, June 2021, Pages 676-680].
Rocconi RP; Monk BJ; Walter A; Herzog TJ; Galanis E; Manning L; Bognar E; Wallraven G; Stanbery L; Aaron P; Senzer N; Coleman RL; Nemunaitis J
Gynecol Oncol; 2023 Feb; 169():173. PubMed ID: 36456375
[No Abstract] [Full Text] [Related]
42. Case of Tuberculated Ovaria.
Renton R
Edinb Med Surg J; 1827 Apr; 27(91):272-278. PubMed ID: 30330076
[No Abstract] [Full Text] [Related]
43. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Pujade-Lauraine E; Ledermann JA; Selle F; Gebski V; Penson RT; Oza AM; Korach J; Huzarski T; Poveda A; Pignata S; Friedlander M; Colombo N; Harter P; Fujiwara K; Ray-Coquard I; Banerjee S; Liu J; Lowe ES; Bloomfield R; Pautier P;
Lancet Oncol; 2017 Sep; 18(9):1274-1284. PubMed ID: 28754483
[TBL] [Abstract][Full Text] [Related]
44. Targeted therapy for ovarian cancer: the rapidly evolving landscape of PARP inhibitor use.
Walsh C
Minerva Ginecol; 2018 Apr; 70(2):150-170. PubMed ID: 28994564
[TBL] [Abstract][Full Text] [Related]
45. The effect of CA125 on metastasis of ovarian cancer: old marker new function.
Yuan Q; Song J; Yang W; Wang H; Huo Q; Yang J; Yu X; Liu Y; Xu C; Bao H
Oncotarget; 2017 Jul; 8(30):50015-50022. PubMed ID: 28637006
[TBL] [Abstract][Full Text] [Related]
46. Targeting DNA repair and replication stress in the treatment of ovarian cancer.
Murai J
Int J Clin Oncol; 2017 Aug; 22(4):619-628. PubMed ID: 28643177
[TBL] [Abstract][Full Text] [Related]
47. A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer.
Tanaka Y; Kunisaki C; Izumisawa Y; Makino H; Kimura J; Sato S; Miyamoto H; Kosaka T; Ono HA; Takahashi M; Sato K; Akiyama H; Endo I
Anticancer Res; 2018 Oct; 38(10):6015-6021. PubMed ID: 30275234
[TBL] [Abstract][Full Text] [Related]
48. Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
Mörth C; Valachis A; Sabaa AA; Molin D; Flogegård M; Enblad G
Ann Hematol; 2018 Nov; 97(11):2129-2135. PubMed ID: 30091025
[TBL] [Abstract][Full Text] [Related]
49. Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.
Shima H; Kutomi G; Satomi F; Imamura M; Kimura Y; Mizuguchi T; Watanabe K; Takahashi A; Murai A; Tsukahara T; Kanaseki T; Hirohashi Y; Iwayama Y; Tsuruma T; Kameshima H; Sato N; Torigoe T; Takemasa I
Cancer Immunol Immunother; 2018 Oct; 67(10):1603-1609. PubMed ID: 30069687
[TBL] [Abstract][Full Text] [Related]
50. Change in Anticancer Drug Sensitivity During Neuronal Differentiation of PC12 Cells.
Sakagami H; Hara Y; Shi H; Iwama S; Nakagawa M; Suzuki H; Tanaka K; Abe T; Tamura N; Takeshima H; Horie N; Kaneko T; Shiratsuchi H; Kaneko T
In Vivo; 2018; 32(4):765-770. PubMed ID: 29936457
[TBL] [Abstract][Full Text] [Related]
51. DNA decorated Cu
Liang S; Xie Z; Wei Y; Cheng Z; Han Y; Lin J
Dalton Trans; 2018 Jun; 47(24):7916-7924. PubMed ID: 29790525
[TBL] [Abstract][Full Text] [Related]
52. Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low‑dose chemotherapeutic agents on gastric cancer cells.
Xin J; Wang S; Zhang L; Xin B; He Y; Wang J; Wang S; Shen L; Zhang Z; Yao C
Oncol Rep; 2018 Jul; 40(1):165-178. PubMed ID: 29767247
[TBL] [Abstract][Full Text] [Related]
53. Emergency department presentations in early stage breast cancer patients receiving adjuvant and neoadjuvant chemotherapy.
Tang M; Horsley P; Lewis CR
Intern Med J; 2018 May; 48(5):583-587. PubMed ID: 29722200
[TBL] [Abstract][Full Text] [Related]
54. Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC).
Zhang Y; Jia QA; Kadel D; Zhang XF; Zhang QB
Med Sci Monit; 2018 May; 24():2735-2743. PubMed ID: 29720580
[TBL] [Abstract][Full Text] [Related]
55. Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer.
Shen H; Li F; Wang D; Yang Z; Yao C; Ye Y; Wang X
Drug Des Devel Ther; 2018; 12():921-934. PubMed ID: 29719378
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation.
Yang X; Yin H; Zhang Y; Li X; Tong H; Zeng Y; Wang Q; He W
Int J Oncol; 2018 Jul; 53(1):215-224. PubMed ID: 29693166
[TBL] [Abstract][Full Text] [Related]
57. Effective delivery of hydrophobic drugs to breast and liver cancer cells using a hybrid inorganic nanocarrier: A detailed investigation using cytotoxicity assays, fluorescence imaging and flow cytometry.
Manatunga DC; de Silva RM; de Silva KMN; Malavige GN; Wijeratne DT; Williams GR; Jayasinghe CD; Udagama PV
Eur J Pharm Biopharm; 2018 Jul; 128():18-26. PubMed ID: 29625162
[TBL] [Abstract][Full Text] [Related]
58. Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study).
Kosugi C; Koda K; Ishibashi K; Yoshimatsu K; Tanaka S; Kato R; Kato H; Oya M; Narushima K; Mori M; Shuto K; Ishida H
Int J Colorectal Dis; 2018 Jun; 33(6):809-817. PubMed ID: 29484450
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.
Nurmi A; Mustonen H; Parviainen H; Peltola K; Haglund C; Seppänen H
Acta Oncol; 2018 Jun; 57(6):799-806. PubMed ID: 29241394
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer.
Castrellon AB; Velez M; Nguyen SM; Blaya M; Barnick S; Dumais K; LeCroy N; Raez LE
Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):30-33. PubMed ID: 29100977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
